Report of Foreign Issuer (6-k)
January 08 2020 - 4:03PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of January, 2020
Commission File Number 1565025
AMBEV S.A.
(Exact name of registrant as specified in its charter)
AMBEV S.A.
(Translation of Registrant's name into English)
Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ___X___ Form 40-F _______
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes _______ No ___X____
INDIVIDUAL FORM
Article 11 - CVM Instruction # 358/2002
In December 2019:
( ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002.(1)
( X ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.
|
Company Name: Ambev S.A.
|
|
Name: Ambev Luxembourg S.À.R.L.
|
CPF/CNPJ:
|
|
Qualification: Position – Total Return Swap
|
Initial Balance
|
|
Securities / Derivatives
|
Securities Characteristics (2)
|
Quantity
|
|
Derivatives
|
Swap referenced in Shares
|
30,039,800
|
|
Derivatives
|
Swap referenced in ADR
|
26,974,653
|
Transactions in the month
|
|
Securities / Derivatives
|
Securities Characteristics (2)
|
Intermediary
|
Operation
|
Day
|
Quantity
|
Price
|
Volume (3)
|
|
|
|
|
|
|
|
|
|
Final Balance
|
|
Securities / Derivatives
|
Securities Characteristics (2)
|
Quantity
|
|
Derivatives
|
Swap referenced in Shares
|
30,039,800
|
|
Derivatives
|
Swap referenced in ADR
|
26,974,653
|
|
|
|
|
|
|
|
|
|
(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.
(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.
(3) Quantity multiplied by price.
(*) In accordance with the Circular Letter/CVM/SEP/Nº07/2017, date information of the total return swap conclusion and not the date of the financial settlement of the transaction.
INDIVIDUAL FORM
Article 11 - CVM Instruction # 358/2002
In December 2019:
( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002.(1)
( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.
|
Company Name: Ambev S.A.
|
|
Name: Ambev S.A.
|
CPF/CNPJ: 07.526.557/0001-00
|
|
Qualification: Outstanding Shares in Treasury
|
Initial Balance
|
|
Securities / Derivatives
|
Securities Characteristics (2)
|
Quantity
|
|
Shares
|
Common
|
3,221,390
|
Transactions in the month
|
|
Securities / Derivatives
|
Securities Characteristics (2)
|
Intermediary
|
Operation
|
Day
|
Quantity
|
Price
|
Volume (3)
|
|
Shares
|
Common
|
Direct with the Company
|
Conversion into ADR
|
16
|
7,002
|
R$ 0.00
|
R$ 0.00
|
|
Shares
|
Common
|
Direct with the Company
|
Conversion into ADR
|
20
|
3,122
|
R$ 0.00
|
R$ 0.00
|
|
Shares
|
Common
|
Direct with the Company
|
Conversion into ADR
|
20
|
5,409
|
R$ 0.00
|
R$ 0.00
|
|
Shares
|
Common
|
Direct with the Company
|
Conversion into ADR
|
23
|
97,667
|
R$ 0.00
|
R$ 0.00
|
|
Shares
|
Common
|
Direct with the Company
|
Conversion into ADR
|
27
|
8,027
|
R$ 0.00
|
R$ 0.00
|
|
|
|
|
Total Conversion into ADR (Sell)
|
|
121,227
|
|
R$ 0.00
|
|
Shares
|
Common
|
Direct with the Company
|
Diferred Shares
|
02
|
8,055
|
R$ 0.00
|
R$ 0.00
|
|
Shares
|
Common
|
Direct with the Company
|
Exerc Options
|
04
|
25,385
|
R$ 11.9720
|
R$ 303,909.22
|
|
Shares
|
Common
|
Direct with the Company
|
Exerc Options
|
09
|
25,385
|
R$ 11.9720
|
R$ 303,909.22
|
|
Shares
|
Common
|
Direct with the Company
|
Exerc Options
|
13
|
46,000
|
R$ 6.9588
|
R$ 320,104.80
|
|
Shares
|
Common
|
Direct with the Company
|
Exerc Options
|
13
|
45,175
|
R$ 9.3596
|
R$ 422,819.93
|
|
Shares
|
Common
|
Direct with the Company
|
Exerc Options
|
13
|
25,385
|
R$ 11.9720
|
R$ 303,909.22
|
|
Shares
|
Common
|
Direct with the Company
|
Exerc Options
|
13
|
19,415
|
R$ 17.1980
|
R$ 333,899.17
|
|
Shares
|
Common
|
Direct with the Company
|
Exerc Options
|
13
|
34,225
|
R$ 17.6820
|
R$ 605,166.45
|
|
Shares
|
Common
|
Direct with the Company
|
Exerc Options
|
16
|
29,125
|
R$ 17.1980
|
R$ 500,891.75
|
|
Shares
|
Common
|
Direct with the Company
|
Exerc Options
|
16
|
16,126
|
R$ 17.5600
|
R$ 283,172.56
|
|
Shares
|
Common
|
Direct with the Company
|
Exerc Options
|
18
|
30,125
|
R$ 9.3596
|
R$ 281,957.95
|
|
Shares
|
Common
|
Direct with the Company
|
Exerc Options
|
18
|
25,385
|
R$ 11.9720
|
R$ 303,909.22
|
|
Shares
|
Common
|
Direct with the Company
|
Exerc Options
|
18
|
38,830
|
R$ 17.1980
|
R$ 667,798.34
|
|
Shares
|
Common
|
Direct with the Company
|
Exerc Options
|
19
|
40,475
|
R$ 6.9588
|
R$ 281,657.43
|
|
Shares
|
Common
|
Direct with the Company
|
Diferred Shares
|
19
|
4,033
|
R$ 0.00
|
R$ 0.00
|
|
Shares
|
Common
|
Direct with the Company
|
Exerc Options
|
23
|
23,300
|
R$ 17.1980
|
R$ 400,713.40
|
|
Shares
|
Common
|
Direct with the Company
|
Exerc Options
|
23
|
29,028
|
R$ 17.5600
|
R$ 509,731.68
|
|
Shares
|
Common
|
Direct with the Company
|
Exerc Options
|
23
|
32,177
|
R$ 16.8500
|
R$ 542,182.45
|
|
|
|
|
Total Sell
|
|
529,881
|
|
R$ 6,932,077.91
|
|
Shares
|
Common
|
Direct with the Company
|
Plan of Shares Acquisition
|
06
|
6,117
|
R$ 18.45
|
R$ 112,858.65
|
|
Shares
|
Common
|
Direct with the Company
|
Plan of Shares Acquisition
|
13
|
104,467
|
R$ 19.01
|
R$ 1,985,917.67
|
|
Shares
|
Common
|
Direct with the Company
|
Plan of Shares Acquisition
|
16
|
41,094
|
R$ 19.08
|
R$ 784,073.52
|
|
Shares
|
Common
|
Direct with the Company
|
Plan of Shares Acquisition
|
18
|
80,570
|
R$ 19.09
|
R$ 1,538,081.30
|
|
Shares
|
Common
|
Direct with the Company
|
Plan of Shares Acquisition
|
20
|
8,961
|
R$ 18.91
|
R$ 169,452.51
|
|
Shares
|
Common
|
Direct with the Company
|
Plan of Shares Acquisition
|
23
|
76,616
|
R$ 18.96
|
R$ 1,452,639.36
|
|
Shares
|
Common
|
Direct with the Company
|
Plan of Shares Acquisition
|
26
|
733,800
|
R$ 19.22
|
R$ 14,103,636.00
|
|
|
|
|
Total Buy
|
|
1,051,625
|
|
R$ 20,146,659.01
|
|
ADR
|
Common
|
Direct with the Company
|
Conversion into ADR
|
16
|
7,002
|
R$ 0.00
|
R$ 0.00
|
|
ADR
|
Common
|
Direct with the Company
|
Conversion into ADR
|
20
|
3,122
|
R$ 0.00
|
R$ 0.00
|
|
ADR
|
Common
|
Direct with the Company
|
Conversion into ADR
|
20
|
5,409
|
R$ 0.00
|
R$ 0.00
|
|
ADR
|
Common
|
Direct with the Company
|
Conversion into ADR
|
23
|
97,667
|
R$ 0.00
|
R$ 0.00
|
|
ADR
|
Common
|
Direct with the Company
|
Conversion into ADR
|
27
|
8,027
|
R$ 0.00
|
R$ 0.00
|
|
|
|
|
Conversion into ADR (Buy)
|
|
121,227
|
|
R$ 0.00
|
|
ADR
|
Common
|
Direct with the Company
|
Plan of Shares Acquisition
|
16
|
32,473
|
R$ 19.0538472
|
R$ 618,735.58
|
|
ADR
|
Common
|
Direct with the Company
|
Plan of Shares Acquisition
|
20
|
24,491
|
R$ 19.0570511
|
R$ 466,726.24
|
|
ADR
|
Common
|
Direct with the Company
|
Plan of Shares Acquisition
|
27
|
5,298
|
R$ 19.0984560
|
R$ 101,183.62
|
|
|
|
|
Total Buy
|
|
62,262
|
|
R$ 1,186,645.44
|
|
ADR
|
Common
|
Direct with the Company
|
Exerc Options
|
16
|
39,475
|
R$ 15.6741122
|
R$ 618,735.58
|
|
ADR
|
Common
|
Direct with the Company
|
Exerc Options
|
20
|
29,900
|
R$ 15.6095732
|
R$ 466,726.24
|
|
ADR
|
Common
|
Direct with the Company
|
Diferred ADR
|
20
|
3,122
|
R$ 0.00
|
R$ 0.00
|
|
ADR
|
Common
|
Direct with the Company
|
Phantom ADR
|
23
|
97,667
|
R$ 15.9180860
|
R$ 1,554,671.70
|
|
ADR
|
Common
|
Direct with the Company
|
Exerc Options
|
27
|
13,325
|
R$ 7.5935174
|
R$ 101,183.62
|
|
|
|
|
Total Sell
|
|
183,489
|
|
R$ 2,741,317.14
|
Final Balance
|
|
Securities / Derivatives
|
Securities Characteristics (2)
|
Quantity
|
|
Shares
|
Common
|
3,621,907
|
|
|
|
|
|
|
|
|
|
|
(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.
(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.
(3) Quantity multiplied by price.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: January 8, 2020
|
|
|
|
|
|
AMBEV S.A.
|
|
|
|
|
|
|
By:
|
/s/ Fernando Mommensohn Tennenbaum
|
|
|
Fernando Mommensohn Tennenbaum
Chief Financial and Investor Relations Officer
|